Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» breast cancer
breast cancer
EntreMed announces initiation of phase 2 trial in triple-negative breast cancer
Yahoo/Fly on the Wall
Wed, 07/25/12 - 09:33 am
EntreMed
triple-negative breast cancer
breast cancer
ENMD-2076
Breast Cancer Halted By Novartis Drug From Easter Island
Bloomberg
Mon, 07/23/12 - 08:50 am
Novartis
Afinitor
breast cancer
Sunshine Biopharma signs Adva-27a manufacturing contract with Beta Pharma
Process and Production
Sat, 07/21/12 - 12:05 pm
Sunshine Biopharma
breast cancer
Beta Pharma
Adva-27a
small cell lung cancer
UPDATE 2-US FDA approves Novartis drug Afinitor for breast cancer
Reuters
Sat, 07/21/12 - 11:51 am
Novartis
Afinitor
breast cancer
Ampio Pharmaceuticals Expands Pipeline with Promising New Cancer Drug NCE001
Motley Fool
Sat, 07/21/12 - 11:42 am
Ampio Pharmaceuticals
NCE001
breast cancer
renal cancer
glioblastoma multiforme
Eisai's Halavan misses endpoints in Phase III trial
Pharma Times, UK
Wed, 07/11/12 - 10:06 am
Eisai
Halavan
Xeloda
breast cancer
NICE turns down Avastin for breast cancer
Fierce Pharma
Fri, 07/6/12 - 11:20 am
Avastin
Roche
breast cancer
NICE
UK
Teva Announces Progress of Biologic Investigational Drugs Evaluated to Treat Neutropenia in Breast Cancer Patients Undergoing Chemotherapy
Pipeline Review
Sat, 06/30/12 - 04:41 pm
Teva Pharmaceuticals
neutropenia
breast cancer
lipegfilgrastim
balugrastim
Novartis' Afinitor recommended by CHMP for EU approval
Yahoo/Fly on the Wall
Fri, 06/22/12 - 09:29 am
Novartis
Afinitor
Europe
CHMP
breast cancer
Protesters push FDA on breast cancer drug at BIO conference
Bizjournals.com
Wed, 06/20/12 - 12:33 pm
FDA
breast cancer
BIO Conference
T-DM1
Immunogen
Roche
PDL's Royalty Agreement with Genentech, and What This Means For Healthcare Stocks
Seeking Alpha
Tue, 06/19/12 - 12:10 pm
breast cancer
PDL Biopharma
Genentech
Roche
Symmetry Medical
Rigel
Medivation
MRI Interventions
BioSante
Horizon Pharma
Pertuzumab
Genentech Eagerly Awaits FDA Word on 2nd Breast Cancer Drug
Xconomy
Fri, 06/8/12 - 11:51 am
FDA
breast cancer
Roche
Perjeta
Pertuzumab
Biotech All Stars Buy Castoff Experimental Merck Cancer Drug
Forbes
Wed, 06/6/12 - 03:30 pm
Merck
Tesaro
niraparib
breast cancer
ovarian cancer
ImmunoGen rises on breast cancer drug data; says Roche plans 3 more T-DM1 studies in 2013
Yahoo/AP
Mon, 06/4/12 - 05:54 pm
Immunogen
Roche
breast cancer
T-DM1
Celegene, Bristol Drugs No Better Than Cheaper Treatments
Bloomberg
Mon, 06/4/12 - 05:41 pm
Celgene
Bristol-Myers Squibb
Ixempra
Abraxane
breast cancer
Study: 'Smart bomb' drug attacks breast cancer
Yahoo/AP
Sun, 06/3/12 - 11:13 am
T-DM1
breast cancer
Genentech
Roche
Puma Biotechnology presents positive PB272 clinical data at ASCO
Yahoo/The Fly On The Wall
Sun, 06/3/12 - 11:07 am
Puma Biotechnology
PB272
breast cancer
Pfizer Cleared Of Liability In Prempro Breast Cancer Case
Bloomberg
Wed, 05/30/12 - 02:58 pm
Wyeth
Prempro
breast cancer
Pfizer
HRT
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
ASCO
Genentech
T-DM1
breast cancer
tivozanib
Aveo
kidney cancer
Onyx
Bayer
regorafenib
colorectal cancer
Adcetris
Seattle Genetics
JNJ
prostate cancer
Zytiga
cabozantinib
Exelixis
Enzalutamide
Medivation
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
Galena Biopharma: How Long Can Big Pharma Wait?
Seeking Alpha
Mon, 04/23/12 - 11:10 am
Galena Biopharma
Roche
NeuVax
breast cancer
Pages
« first
‹ previous
…
22
23
24
25
26
27
28
29
30
…
next ›
last »